Pixel-art hackathon collaboration workstation — dominant investigation board center with red string connecting node cards; Stanley full brand anchors right; anonymous collaborator silhouette with headphones and tablet (no identifiable face). Stanford rare-disease research aesthetic.
Rare Disease Active

Research to the People — Stanford

ML Scientist at Stanford Genetics and Stanford Medicine — building AI infrastructure for rare disease diagnosis, precision oncology, and scientific foundation models.

stanfordrare-diseaseprecision-oncologygenomicshackathon
Collaborators: Stanford Genetics · Stanford Medicine · Wilhelm Foundation · Mayo Clinic · CZI

Research to the People (RTTP) is a joint Stanford Genetics and Stanford Medicine program that unites clinicians, data scientists, patients, and researchers to tackle unaddressed problems in rare genetic illness medicine and precision oncology. My role: contribute AI expertise and leadership to a research program working on omic foundation models, viral phylogenetics, and onco-viral protein dynamics.

The proudest contribution from the RTTP era is the Rare Disease AI Hackathon — which I architected from the ground up. The concept: bring together diverse contributors from clinical science, genetics, ML, and patient advocacy to find high-leverage places where AI raises the standard of care. What started with a small team at Stanford grew into an international movement. Partners now include Roche, HuggingFace, OpenAI, The Rare Care Center, and more. 250+ engineering volunteers across events. 30+ countries represented. Six diagnoses in 48 hours at Mayo Clinic in 2025.

Despite moving on from RTTP, the mission continues through the Wilhelm Foundation, where I serve as Lead AI Architect. The Palo Alto garage spirit — “let’s build it with a small, elite team” — scales when the garage is a global network of people who believe no disease is too rare to matter.